BG103252A - The use of benzopyranols for the treatment of neurological disorders - Google Patents

The use of benzopyranols for the treatment of neurological disorders

Info

Publication number
BG103252A
BG103252A BG103252A BG10325299A BG103252A BG 103252 A BG103252 A BG 103252A BG 103252 A BG103252 A BG 103252A BG 10325299 A BG10325299 A BG 10325299A BG 103252 A BG103252 A BG 103252A
Authority
BG
Bulgaria
Prior art keywords
treatment
pains
benzopyranols
neurological disorders
neuralgia
Prior art date
Application number
BG103252A
Other languages
Bulgarian (bg)
English (en)
Inventor
Andrew Parsons
Mervyn Thompson
Neil Upton
Johan EVANS
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of BG103252A publication Critical patent/BG103252A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
BG103252A 1996-09-18 1999-03-15 The use of benzopyranols for the treatment of neurological disorders BG103252A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9619492.3A GB9619492D0 (en) 1996-09-18 1996-09-18 Novel treatment
PCT/EP1997/005168 WO1998011890A1 (en) 1996-09-18 1997-09-15 Use of benzopyranols to treat neurological disorders

Publications (1)

Publication Number Publication Date
BG103252A true BG103252A (en) 1999-09-30

Family

ID=10800127

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103252A BG103252A (en) 1996-09-18 1999-03-15 The use of benzopyranols for the treatment of neurological disorders

Country Status (30)

Country Link
EP (1) EP0939630B1 (de)
JP (1) JP2001500520A (de)
KR (1) KR20000036184A (de)
CN (1) CN1230885A (de)
AP (1) AP9901473A0 (de)
AR (1) AR008838A1 (de)
AT (1) ATE270102T1 (de)
AU (1) AU730465B2 (de)
BG (1) BG103252A (de)
BR (1) BR9712030A (de)
CA (1) CA2266681A1 (de)
DE (1) DE69729735T2 (de)
DZ (1) DZ2311A1 (de)
EA (1) EA199900306A1 (de)
ES (1) ES2223075T3 (de)
GB (1) GB9619492D0 (de)
HU (1) HUP9904638A3 (de)
ID (2) ID23175A (de)
IL (1) IL128786A0 (de)
MA (1) MA24321A1 (de)
NO (1) NO991292D0 (de)
NZ (1) NZ334271A (de)
OA (1) OA10998A (de)
PE (1) PE109898A1 (de)
PL (1) PL332313A1 (de)
SK (1) SK35199A3 (de)
TR (1) TR199900527T2 (de)
UY (1) UY24717A1 (de)
WO (1) WO1998011890A1 (de)
ZA (1) ZA978359B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
US20130281524A1 (en) * 2008-06-05 2013-10-24 Peter Blower Novel treatments
MX2010013312A (es) * 2008-06-05 2011-05-30 Minster Res Ltd Tratamientos novedoos.
ES2642586T3 (es) 2009-07-27 2017-11-16 Gilead Sciences, Inc. Compuestos heterocíclicos condensados como moduladores de canales iónicos
US20130018091A1 (en) * 2009-12-03 2013-01-17 Peter Blower Treatment of allodynia and hyperalgesia
EP2506847A1 (de) * 2009-12-03 2012-10-10 Proximagen Limited Behandlung von infektionserkrankungen
EP2588197B1 (de) 2010-07-02 2014-11-05 Gilead Sciences, Inc. Kondensierte heterozyklische verbindungen als ionenkanalmodulatoren
KR20140033377A (ko) 2011-05-10 2014-03-18 길리애드 사이언시즈, 인코포레이티드 나트륨 채널 조절제로서의 융합된 헤테로시클릭 화합물
NO3175985T3 (de) 2011-07-01 2018-04-28
UY34171A (es) 2011-07-01 2013-01-31 Gilead Sciences Inc Compuestos heterocíclicos fusionados como moduladores del canal iónico
CN106397317B (zh) * 2016-09-26 2019-03-22 天津师范大学 1,2,3,4-四氢喹啉化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
US5510375A (en) * 1993-11-19 1996-04-23 Warner-Lambert Company Coumarin derivatives as protease inhibitors and antiviral agents
CN1174975C (zh) * 1994-06-10 2004-11-10 史密丝克莱恩比彻姆有限公司 苯并吡喃类化合物和它们作为治疗剂的用途
GB9411635D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
EP0939630A1 (de) 1999-09-08
AR008838A1 (es) 2000-02-23
AU730465B2 (en) 2001-03-08
DZ2311A1 (fr) 2002-12-28
HUP9904638A2 (hu) 2001-05-28
JP2001500520A (ja) 2001-01-16
EA199900306A1 (ru) 1999-08-26
PL332313A1 (en) 1999-08-30
SK35199A3 (en) 2000-07-11
MA24321A1 (fr) 1998-04-01
ATE270102T1 (de) 2004-07-15
CA2266681A1 (en) 1998-03-26
ZA978359B (en) 1999-03-17
UY24717A1 (es) 2001-08-27
HUP9904638A3 (en) 2001-08-28
AU4704797A (en) 1998-04-14
PE109898A1 (es) 1999-03-21
BR9712030A (pt) 1999-08-24
KR20000036184A (ko) 2000-06-26
CN1230885A (zh) 1999-10-06
AP9901473A0 (en) 1999-03-31
TR199900527T2 (xx) 1999-06-21
EP0939630B1 (de) 2004-06-30
ES2223075T3 (es) 2005-02-16
NO991292L (no) 1999-03-17
WO1998011890A1 (en) 1998-03-26
GB9619492D0 (en) 1996-10-30
ID23175A (id) 2000-03-23
DE69729735T2 (de) 2005-07-14
ID19542A (id) 1998-07-23
DE69729735D1 (de) 2004-08-05
NO991292D0 (no) 1999-03-17
NZ334271A (en) 2001-03-30
OA10998A (en) 2003-03-04
IL128786A0 (en) 2000-01-31

Similar Documents

Publication Publication Date Title
IN172468B (de)
AU2001236904A1 (en) Deep brain stimulation system for the treatment of parkinson's disease or other disorders
AU2001273574A1 (en) Substituted 5-alkynyl pyrimidines having neurotrophic activity
GB0108592D0 (en) Therapeutic agents
WO1998020864A3 (en) Use of selected non-steroidal antiinflammatory compounds for the prevention and the treatment of neurodegenerative diseases
TW264480B (de)
AP2004003069A0 (en) 3-beta-d-ribofuranosynthiazolo [4-5-d] pyridimine nucleosides and uses thereof.
WO2001009118A3 (en) Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement
FR2706767B1 (de)
GEP20094798B (en) (s,s)-reboxetine for treating chronic pain
AU2160492A (en) Treatment of human diseases involving dysregulation or dysfunction of the nervous system
WO2003041643A3 (en) Hsp90-inhibiting zearalanol compounds and methods of producing and using same
BG103252A (en) The use of benzopyranols for the treatment of neurological disorders
IL110943A (en) Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
GR3022356T3 (en) Use of lamotrigine for treating aids-related neural disorders
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
ZA977310B (en) Transdermal propentofylline compositions for the treatment of Alzheimer's disease.
MY157745A (en) Method of treating of demyelinating diseases or conditions
EP1032556A4 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
WO2000021513A3 (en) Methods for treating multiple sclerosis
GB9425730D0 (en) Compounds
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
BG102079A (en) Alkylaminoderivatives of substituted quinoxalin-2,3-dions such as glutamatereceptor antagonists
CA2294243A1 (en) Novel cyanoaziridines for treating cancer
ZA985668B (en) (S)-2-methylamino-2-phenyl-n-butyl 3,4,5-trimethoxy benzoate its application to the treatment of chronic pain